日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

E7386 Enhances Lenvatinib's Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma.

E7386 增强了乐伐替尼在临床前模型和人类肝细胞癌中的抗肿瘤活性。

Mesropian Agavni, Gris-Oliver Albert, Balaseviciute Ugne, Potdar Alka A, Kimura Takayuki, Shen Jialing, Torres-Marcén Martí, Abril-Fornaguera Jordi, Piqué-Gili Marta, Camell-Raventos David, Peix Judit, Fernández-Martínez Elisa, Huguet-Pradell Júlia, Hernández de Sande Ana, Keraite Ieva, Esteban-Fabró Roger, Bárcena-Varela Marina, Lindblad Katherine E, Lujambio Amaia, Guccione Ernesto, Thung Swan, Ikeda Masafumi, Kudo Masatoshi, Sia Daniela, Pinyol Roser, Llovet Josep M

Genome-wide CRISPR Screening Identifies NFκB and c-MET as Druggable Targets to Sensitize Lenvatinib Treatment in Hepatocellular Carcinoma.

全基因组 CRISPR 筛选发现 NFβ 和 c-MET 是可药物靶点,可增强 Lenvatinib 对肝细胞癌的治疗效果

Wan Ting-Chi Rebecca, Wei Lai, Cheng Lai-Hung, Chin Wai-Ching, Shen Jialing, Chan For-Fan, Kuang Zhijian, Wang Cun, Wong Carmen Chak-Lui, Wong Chun-Ming

The Role of Gluten in Food Products and Dietary Restriction: Exploring the Potential for Restoring Immune Tolerance

麸质在食品和饮食限制中的作用:探索恢复免疫耐受性的潜力

Ye, Li; Zheng, Wenyu; Li, Xue; Han, Wenmin; Shen, Jialing; Lin, Qiuya; Hou, Liyan; Liao, Lan; Zeng, Xin'an

IL-1β in atherosclerotic vascular calcification: From bench to bedside

IL-1β在动脉粥样硬化血管钙化中的作用:从实验室到临床

Shen, Jialing; Zhao, Ming; Zhang, Chunxiang; Sun, Xiaolei